Istari Oncology, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Durham NC United States (2014)

Organization Overview

First Clinical Trial
2018
NCT03564782
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Istari Oncology, Inc.